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A B S T R A C T
The multiple specialized cell types of the hematopoietic system originate from differentiation of hematopoietic
stem cells and progenitors (HSPC), which can generate both lymphoid and myeloid lineages. The myeloid
lineage is preferentially maintained during ageing, but the mechanisms that contribute to this process are in-
completely understood. Here, we studied the roles of Wnt5a and Wnt5b, ligands that have previously been linked
to hematopoietic stem cell ageing and that are abundantly expressed by both hematopoietic progenitors and
bone-marrow derived niche cells. Whereas Wnt5a had no major effects on primitive cell differentiation, Wnt5b
had profound and divergent effects on cytokine-induced myeloid differentiation. Remarkably, while IL-3-
mediated myeloid differentiation was largely repressed by Wnt5b, GM-CSF-induced myeloid differentiation was
augmented. Furthermore, in the presence of IL-3, Wnt5b enhanced HSPC self-renewal, whereas in the presence
of GM-CSF, Wnt5b accelerated differentiation, leading to progenitor cell exhaustion. Our results highlight dis-
crepancies between IL-3 and GM-CSF, and reveal novel effects of Wnt5b on the hematopoietic system.
1. Introduction
Effective immunity and tissue homeostasis throughout life depend
on the ability of hematopoietic stem cells and progenitors (HSPC) to
generate a balanced supply of the specialized lymphoid and myeloid
cell types that constitute the hematopoietic system [53]. Myeloid
lineage commitment initiates from the common myeloid progenitor,
which differentiates to give rise to critical components of the innate
immune system including granulocytes, monocytes and mast cells, in
addition to platelets and erythrocytes [53]. Recent studies indicate that
the myeloid lineage is preferentially maintained over the lymphoid
lineage during ageing [14,19,21,37] and this so-called myeloid skewing
is of interest as it may contribute to the development of chronic diseases
associated with ageing. In this context, it is of great interest to under-
stand how the molecular and microenvironmental changes that occur
during ageing impact on myeloid differentiation as this may yield po-
tential therapeutic targets.
Myeloid lineage development is regulated by a complex network of
molecules. Of central importance are cytokines and growth factors
produced by the bone marrow microenvironment [6,24,44,64], which
comprises numerous cells types of both hematopoietic origin, including
monocytes and lymphocytes, and non-hematopoietic origin, including
fibroblasts, adipocytes and endothelial cells [3,24,68]. Interleukin-3
(IL-3) and granulocyte macrophage-colony stimulating factor (GM-
CSF), produced by monocytes and lymphocytes, have particularly cru-
cial roles in myeloid differentiation [24,64]; GM-CSF is also produced
by non-hematopoietic bone marrow cells [3,6,52]. IL-3 and GM-CSF
have overlapping activities [9,44,47], including regulating proliferation
and differentiation of myeloid progenitors [2,44], stimulation of gran-
ulocyte-monocyte-biased colony formation in colony formation unit
(CFU) assay [47] and activation of granulocytes and monocytes
[2,9,44]. In primitive hematopoietic cells, similar intracellular proteins
are recruited to generate the cited outcomes, such as PLCγ2, calmodulin
kinase and MEK/ERK signaling [35], although PKC activation is not
observed after GM-CSF treatment and the pattern of activation of MEK/
ERK varies [35].
Primitive cells including HSCs (hematopoietic stem cells) and mul-
tipotent progenitors are more sensitive to IL-3, which supports stem cell
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maintenance [15–17], whilst committed myeloid progenitors are more
sensitive to GM-CSF, which drives differentiation and proliferation
[15–17].
Numerous Wnt signaling components have been identified within
the bone marrow microenvironment [57,63,66], and some of these
appear to play significant roles in hematopoietic ageing [19,32,36].
Wnt ligands induce intracellular signaling events by binding to cell
surface frizzled (Fzd) receptors, stimulating either β-catenin dependent
(canonical) or independent (non-canonical) signaling pathways [51];
non-canonical Wnt signaling can also be mediated by interactions with
cell surface receptor tyrosine kinases of the Ror and Ryk families [25].
The Wnt5 subfamily of Wnt ligands is of particular interest as both
Wnt5a and Wnt5b are expressed by primitive hematopoietic cells
[8,50,54,55] and niche cells [19,41,42,48,54,58,71]. Wnt5a and Wnt5b
are structurally related with high amino acid sequence similarity [31].
However, Wnt5a and Wnt5b are expressed in non-overlapping patterns
during mouse development [20], and functional differences have been
described for Wnt5a and Wnt5b in regulation of chondrocyte differ-
entiation [72], and mammary epithelial cell growth [31].
Wnt5a and Wnt5b are expressed during embryonic hematopoietic
initiation [12], and regulate hematopoietic cell fate during adult blood
homeostasis [12,19]. Importantly, recent studies revealed that Wnt5a
expression by HSCs increases with age, leading to augmented hallmarks
of hematopoietic senescence [19] and to imbalances in Notch and
calcium pathways [21].
Altogether, these studies led us to hypothesize that Wnt5a and
Wnt5b contribute to age-related increases in cytokine-driven myeloid
differentiation. We thus investigated the role of Wnt5a and Wnt5b in
cytokine-induced HSPC myeloid differentiation using an in vitro colony
formation unit (CFU) assay [45], with IL-3 and GM-CSF treatment to
stimulate differentiation down myeloid lineages. We found that Wnt5a
and Wnt5b had profound and divergent effects on cytokine-induced
myeloid differentiation. Remarkably, while IL-3-mediated myeloid
differentiation was largely repressed by Wnt5b, GM-CSF-induced
myeloid differentiation was augmented. Furthermore, in the presence
of IL-3, Wnt5b enhanced HSPC self-renewal, whereas in the presence of
GM-CSF, Wnt5b accelerated differentiation, leading to progenitor cell
exhaustion. Our results highlight discrepancies between IL-3 and GM-
CSF, and reveal novel effects of Wnt5b on the hematopoietic system.
2. Methods
2.1. Animal models
Adult (2 to 4 months old) C57Bl/6 J specified pathogen-free mice of
both sexes were used for this study. Mice were housed at the UMCG
(University Medical Center Groningen, The Netherlands) Central
Animal Facility and CEDEME (Centro de Desenvolvimento de Modelos
Experimentais para Biologia e Medicina, from UNIFESP – Universidade
Federal de São Paulo, Brazil) and kept in a controlled habitat under a
12/12 h dark-light cycle, with food and water ad libitum. All experi-
mental procedures followed ethical research guidelines and were ap-
proved by ethical committees in both institutions (AVD105002015303
and 1,522,060,515, for University of Groningen and UNIFESP, respec-
tively).
2.2. Hematopoietic cell extraction
To obtain hematopoietic cells, animals were euthanized by cervical
dislocation or by deep anesthesia using ketamine/dexdomitor following
rapid exsanguination via the abdominal aorta. Afterwards, femurs were
collected. Femoral content was flushed out with a syringe filled with
IMDM medium and homogenized. The homogenate was incubated at
37 °C for 2 h in order to reduce the presence of adherent mononuclear
cells in the supernatant. Afterwards, the supernatant was separated;
cells were counted and used for experiments.
2.3. Colony formation units assay (CFU) and replating
We investigated hematopoietic progenitor potential using the
colony forming unit (CFU) assay, in which 5 × 104 bone marrow cells
were seeded into a semi-solid medium (MethoCult M3134, StemCell
Technologies – Vancouver, Canada) and the number of resulting co-
lonies are counted manually using a light microscope at 10× magni-
fication [45]. Cells were plated in 1 mL of this medium supplemented
with 10% FBS, 0,1% bovine serum albumin and 1% penicillin/strep-
tomycin and incubated at 37 °C and 5% CO2 for 2 weeks for the first
round of colony reading. The treatments consisted of: IL-3 (10 ng/mL),
IL-3 (10 ng/mL) + Wnt5a (50 and 200 ng/mL representing EC50 and
submaximal response in other cell systems, respectively [4], IL-3
(10 ng/mL) + Wnt5b (50 and 200 ng/mL). The same co-treatments
were done using GM-CSF (10 ng/mL). Cytokines (403-ML and 415-ML
for IL-3 and GM-CSF, respectively) and Wnt ligands (references 645-WN
and 7347-WN for Wnt5a and 5b, respectively) were purchased from R&
D systems (Minneapolis, USA). AS control for β-catenin signaling acti-
vation, CHIR99021 (2 μM) was used as well, in the presence of IL-3 and
GM-CSF.
After 2-weeks of incubation, there was a first round of colony
reading. Colonies were counted according to subtype and areas of co-
lonies were measured. After this, colonies were dissociated (after cen-
trifugation and resuspension) and counted (for the calculation of cells
by colony ratio and total number of cells per plate). For the replating
assay, after dissociation and counting, cells were plated back into semi-
solid medium for two more weeks and this was subsequently repeated
until colonies were no longer formed. The treatments used previously
were repeated. Half-way during the first round, directly after the first
round and after the second round of reading, some plates were used for
gene expression and flow cytometry analysis (Fig. 1).
After the first round of colony reading, for some experiments, plates
passed through mechanical separation of colonies by subtype and the
replating was done for each subtype individually. After replating, cells
were again incubated for 2 weeks and read thereafter.
After 2 weeks, some colonies were also isolated by subtype and
replated, differently of the previously described, in which all colonies
were replated together.
2.4. Liquid culture (LC)
Cells were incubated in IMDM supplemented with 10% fetal bovine
serum, 1% penicillin/streptomycin and 10−6 M hydrocortisone for
1 week, and treated with IL-3/GM-CSF in the absence and presence of
Wnt5b. The concentration of cells used for this assay was 1 × 106 cells/
mL. We used the same starting population as before to mirror the po-
pulation used in the CFU assay. After 1 week, cells were washed,
counted and analyzed by flow cytometry.
2.5. Flow cytometry
Cells acquired from the CFU and LC assays were analyzed by flow
cytometry to provide information about primitive cell maintenance,
differentiation and cell death. All cells were stained in PBS with 0,1%
bovine serum albumin and incubated at room temperature protected
from light for 20–40 min prior to flow cytometry reading, except for cell
death experiments, in which annexin buffer (pH 7.4) was used (0.1 M
Hepes, 1.4 M NaCl, and 25 mM CaCl2).
CFU cells were used after 1, 2 and 4 weeks of incubation and the
panel used for primitive cells maintenance and cell death was: Annexin
V-FITC, Lin cocktail-PE (B220, CD3e, CD11b, TER119 and Ly-6-G/C), 7-
AAD and c-Kit-APC (CD117) and for differentiation, Gr-1-FITC (Ly-6G/
Ly-6C), B220-PE, Mac-1- PECy7 (CD11b) and c-Kit-APC (CD117). For
LC cells, panels used were: for primitive cells maintenance, Lin-PE
cocktail, Sca-1-PECy7 (Ly-6A/E) and c-Kit-APC (CD117), for differ-
entiation, F4/80-FITC, Gr-1-PE, Mac-1-PECy7 and TER119-APC, and for
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cell death, Annexin V-FITC, Lin-PE cocktail, 7-AAD and c-Kit-APC. All
antibodies used were purchased from BD Biosciences and equipment
used was Accuri C6, from BD Biosciences as well (Michigan, USA).
Flow cytometry was used to semi-quantify GSK3β phosphorylation
after IL-3 and GM-CSF treatment as well. For this, bone marrow-derived
cells were incubated with the respective cytokine for 15, 20 and 30 min
at 37 °C and agitation, followed by fixation with 2% paraformaldehyde
(Becton Dickinson) for 15, 20 and 30 min, washing with 0.1 M glycine
and permeabilization with 0.001% triton X-100. Primary antibody la-
beling was done using rabbit p-GSK3β (#5558, Cell Signaling) for 2 h
and secondary, goat Anti-rabbit Alexa Fluor 488 (Invitrogen) for an-
other 2 h. p-GSK3β phosphorylation was calculated as the ratio of the
geometric mean of histogram fluorescence signal between treated and
untreated samples. The same panel of conjugated antibodies used for
primitive cell maintenance after LC was used here as well. For HSPC
population gating, we used the Lin−Sca-1+c-Kit+ immunophenotype,
whereas for progenitor population, Lin− Sca-1−c-Kit+ was used. Same
Lin cocktail was used in CFU assay samples, together with viability
markers Annexin V and 7AAD. The gating strategy is also represented in
Supplementary Fig. 1.
2.6. RT-PCR
Cells were harvested at the indicated time points after the CFU
assay, washed and dissociated in PBS. Total RNA was then isolated
using Trizol (ThermoFisher Scientific, Massachusetts, USA) according
to the manufacturer's instruction. The total RNA concentration was
measured using the NanoDrop ND1000 spectrophotometer (Thermo
Scientific, Wilmington, USA). Total RNA was reverse transcribed using
the Reverse Transcription System (Promega; Madison, USA). For RT-
PCR, cDNA was combined with FastStart Universal SYBR Green Master
Mix (Roche Applied Science; Penzberg, Germany) and specific primer
Fig. 1. Experimental design.
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sets (Biolegio; Nijmegen, the Netherlands) using the Eco Personal qPCR
system (Illumina, California, USA). Primer sequences are listed in
Supplementary Table 1. The qPCR protocol started with activation at
95 °C for 15 min, followed by 45 cycles of denaturation at 94 °C for 30 s,
annealing at 59 °C for 30 s and elongation at 72 °C for 30 s. A final
elongation step of 5 min at 72 °C was added at the end of the protocol.
Data was analyzed using LinRegPCR software and results were ex-
pressed as ratio of the starting concentration (N0) of each gene of in-
terest corrected to the geometric mean of the N0 value of 2 reference
genes (GAPDH and β-actin).
2.7. Statistics
Data are shown as means± SEM, except for colony area measure-
ments, for which the median (median is usually presented with inter-
quartile range) is shown. Statistical differences between means were
evaluated by a Student's t-test or a Mann-Whitney U test, in case of
comparisons between two groups, as appropriate. All experiments were
repeated with cells obtained from at least 3 animals. Differences were
considered significant when p < .05.
3. Results
3.1. Divergent effects of Wnt5a and Wnt5b on IL-3- and GM-CSF-induced
myeloid differentiation
We investigated the roles of Wnt5a and Wnt5b on HSPC potential
using an in vitro colony formation unit (CFU) assay, with IL-3 and GM-
CSF treatment to stimulate differentiation down myeloid lineages.
Specific differentiation outcomes were determined by formation of GM-
CFU (granulocyte-monocyte colony formation units), M-CFU (monocyte
colony formation units) or G-CFU (granulocyte colony formation units).
Between these types of colonies, GM-CFU is the most primitive subtype
and mostly formed by common myeloid progenitors and granulocyte-
macrophage progenitors [26,30,38]. A characteristic of its higher de-
gree of primitiveness is the bipotency observed, whereas M and G-CFU
are unipotent [38]. In the presence of IL-3, Wnt5a was unable to affect
colony formation at either 50 ng/mL or 200 ng/mL (Fig. 2A–D). Wnt5b,
on the other hand, inhibited colony formation at the higher con-
centration, affecting mainly the GM and M subtypes (GM-CFU:
11.50 ± 2.6 for IL-3 and 3.33 ± 1.4 for IL-3 + Wnt5b; M-CFU:
33.88 ± 3.5 for IL-3 and 18.33 ± 1.8 for IL-3 + Wnt5b, p < .05,
Figs. 2A–D). The same batches of Wnt5a were used in parallel experi-
ments and were found to repress lung organoid formation, confirming
its biological activity.
In the presence of GM-CSF, Wnt5a had no effect on total myeloid
colony number or number of specific colony subtypes (Fig. 2E). In
contrast, Wnt5b significantly increased total number of colonies formed
(72.88 ± 4.6 for GM-CSF and 112.50 ± 2.3 for GM-CSF + Wnt5b –
200 ng/mL, p < .05, Fig. 2E). This was attributed to increased number
of M and G-CFU subtype colonies (M-CFU: 45.50 ± 6.8 for GM-CSF,
70.86 ± 10.1 for GM-CSF +Wnt5b – 50 ng/mL, 80.17 ± 2.0 for GM-
CSF + Wnt5b – 200 ng/mL; G-CFU: 12.50 ± 2.2 for GM-CSF and
20.67 ± 1.3 for GM-CSF + Wnt5b – 200 ng/mL, all p < .05,
Fig. 2F–H). Interestingly, a significant decrease in the GM-CSF colony
subtype was observed at the lowest concentration (14.00 ± 2.5 for
GM-CSF and 7.00 ± 1.1 for GM-CSF + Wnt5b – 50 ng/mL; p < .05,
Fig. 2F). These data indicate substantial differences between Wnt5a and
-b in regulating myelopoiesis, and show that Wnt5b has divergent ef-
fects on myelopoiesis induced by IL-3 and GM-CSF.
3.2. IL-3 and GM-CSF have similar effects on myeloid differentiation
As previously discussed, there are similarities between IL-3 and GM-
CSF intracellular signaling [29,35,56,60], what do not is in seeming
contrast to the differential Wnt5b effects on these contexts and in the
promotion of myeloid differentiation. In view of the observed differ-
ences in concerted action with Wnt5b, we decided to compare the cell
populations obtained with IL-3 and GM-CSF in more detail. Even
though it is well-described how similar the outcomes of the IL-3 and
GM-CSF treatment are, we aimed to assure that the observed differences
in the Wnt5b effects were not caused by any experimental differences in
IL-3 and GM-CSF themselves. IL-3 and GM-CSF produced very similar
total myeloid colony numbers (Fig. 3A) and had similar effects on the
colony subtype distribution for GM-CFU, M-CFU or G-CFU. A similar
result was obtained for colony size (Fig. 3B).
Colonies were then replated to address effects on the progenitor cell
population and their potential. As shown in Fig. 3C and D, the colony
forming ability was maintained slightly longer in the presence of IL-3
than in the presence of GM-CSF (half-life = 1.4 rounds for IL-3, and 1.0
round for GM-CSF, Fig. 3C and D – this difference was not statistically
significant), whereas the average number of cells per colony after the
first CFU round was not different between IL-3 and GM-CSF (Fig. 3E).
The liquid culture assay showed no major difference either, with very
similar numbers of cells in the presence of IL-3 and GM-CSF (Fig. 3F).
IL-3 and GM-CSF-driven myelopoiesis was investigated further by
analysis of cell surface marker expression. The relative proportion of
committed (Lin+) and non-committed cell (Lin−) cell numbers ob-
served after 1 week of liquid culture was similar for IL-3 and GM-CSF
(Figs. 3G and H). However, the percentage of the primitive population
Lin−c-Kit+ cells was maintained at higher levels with IL-3 than with
GM-CSF (1.38 ± 0.4 in IL-3, 0.24 ± 0.2 in GM-CSF, p < .05, Fig. 3I).
Further, when analyzing subpopulations from the CFU assay, we ob-
served an initial increase in the number of Lin+ cells compared to Lin−
cells in response to Wnt5b and GM-CSF (Supplementary Fig. 3),
whereas no Wnt5b influence is observed in presence of IL-3. A further
analysis shows that Wnt5b promotes early apoptosis of Lin+ cells in
combination with GM-CSF, which is not observed in combination with
IL-3 (Supplementary Fig. 3). Altogether, these data indicate that IL-3
and GM-CSF produce very similar outcomes, although IL-3 maintains
the number of primitive cells better in comparison to GM-CSF. Inter-
estingly, in response to IL-3, phosphorylation of GSK3β can be observed
in (committed) progenitor cells (Prog - Lin−Sca-1−c-Kit+ − the his-
tograms are shown in Supplementary Fig. 2), which is not seen for GM-
CSF (Fig. 3K). Although GSK3β phosphorylation is an indicative of
pathway activation, we are aware of the need for more investigation for
the mechanistic understanding of the observed differences. For these,
we used bone marrow cells of the TCF/Lef:H2B-GFP fusion Wnt re-
porter mice [18], but no obvious GFP signal in bone marrow-derived
cells was found and we could not detect overt localization of β-catenin
protein using immunofluorescence microscopy, either at baseline or in
response to cytokine stimulation. In line with these observations, in
western analyses of lysates of non-adherent cells exposed to GM-CSF or
IL-3 in the absence and presence of WNT-5B we were unable to detect
changes in total β-catenin content and did not detect active (non-
phospho) β-catenin expression (data not shown).
3.3. Wnt5b maintains primitive progenitors in the presence of IL-3
To further investigate the effects of Wnt5b on IL-3-driven myelo-
poiesis, and with this difference between IL-3 and GM-CSF in mind, the
colonies formed in the presence of IL-3 and Wnt5b were dissociated and
replated. With every round of replating, the number of colonies formed
decreased (colony number half-life = 1.4 rounds for IL-3 alone) until
after 5 rounds of replating, essentially no colonies were maintained
(Fig. 4A). The number of colonies formed in the presence of IL-3 and
Wnt5b was much higher in the second round of replating (a 6-fold
difference compared to round 1–48.44 ± 4.5 for the first round and
329.67 ± 82.2 for the second, p < .05, Fig. 4B). In addition, the
colony number half-life was twice as long in the presence of Wnt5b (2.9
rounds for IL-3 and Wnt5b, Figs. 4A and B; p < .05, two-way ANOVA).
To investigate whether the increased colony formation at round 2
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was caused by an increase in the number of colony-forming cells,
colony size was measured directly after the first round. Wnt5b did not
influence colony size (Fig. 4C). Wnt5b did not affect the average
number of cells per colony either (Fig. 4D). To check if the increased
colony-forming potential was specifically maintained in a single sub-
population, first analyzed the ratio between Lin+ and Lin− cells after
1 week of CFU, but there was no change in this parameter in presence of
Wnt5b (Supplementary Fig. 3A) and then, we replated isolated subtypes
of colonies (G, GM and M) but found no differences between these
colony subtypes either (Fig. 4E).No difference between populations,
colonies sizes or number of cells by colony suggested that Wnt5b would
influence functionality (such as potential maintenance or differentia-
tion) of the hematopoietic cells, rather than induce proliferation and
population imbalance. Thus, intracellular components were analyzed.
We therefore analyzed gene expression patterns of colonies treated
with IL-3 and Wnt5b in more detail after 1 week and 2 weeks of
treatment for general markers of cell cycle progression and differ-
entiation. There was no difference in cell cycle markers after 1 week of
culture – Figs. 4F and G). However Cdk1 expression increased and cy-
clin D1 tended to increase after 2 weeks (Cdk1: 0.015 ± 0.0 for IL-3
and 0.034 ± 0.0 for IL-3 +Wnt5b, p < .05, Figs. 4H-I). The primitive
cell markers GATA-2 and Ifitm-1 showed a similar pattern (Ifitm-1:
3.035 ± 0.2 for IL-3 and 3.730 ± 0.6 for IL-3 + Wnt5b, p < .05,
Fig. 4J-M). No effects on more mature markers (Irf8 and Gfi-1) were
observed (not shown). No change in DKK-1, Axin2 or LRP5 gene ex-
pression was observed (Fig. 4O and N). To check how non-canonical
Wnt signaling could be affected by Wnt5b treatment in presence of IL-3,
we also analyzed gene expression of signature genes involved in non-
canonical Wnt signaling. 3 genes were selected with known roles in
noncanonical signaling, being c-Jun, c-Fos and Cdc42. As can be seen in
Fig. 4Q-T, the presence of Wnt5b in combination with IL-3 inhibited the
expression of these genes.
3.4. Wnt5b induces committed progenitor activation and progenitor
exhaustion in the presence of GM-CSF
We next investigated the effects of Wnt5b on GM-CSF-driven mye-
lopoiesis. In sharp contrast to IL-3, Wnt5b had no effects whatsoever on
the kinetics of decay of GM-CSF-induced colony number or subtype
after replating (Fig. 5A and B), with colony number half-lives being
identical (1.0 round for both conditions). Wnt5b did significantly de-
crease average colony size compared to GM-CSF alone
(6.8 × 105 ± 3.3 × 104 for GM-CSF and 5.1 × 105 ± 2.2 × 104 for
GM-CSF +Wnt5b, p < .05, Fig. 5C). Wnt5b treatment had no effect on
the average number of cells per colony (Fig. 5D). When replating in-
dividual subtypes of colonies, Wnt5b decreased the number of GM-CFU
and M-CFU (GM-CFU: 7.21 ± 0.7 for GM-CSF and 3.33 ± 0.7 for GM-
CSF for GM-CSF + Wnt5bp < .05; M-CFU: 6.00 ± 1.1 for GM-CSF
and 2.90 ± 0.5 for GM-CSF + Wnt5b, p < .05, Fig. 5E).
In contrast to what was observed for the presence of IL-3, in the
presence of GM-CSF, Wnt5b did not have any effect on gene expression
of Cdk1 or CyclinD1 after 2 weeks of the CFU assay (Fig. 5G and H), or
at any other time point (data not shown). There was no difference in the
primitive cell markers GATA-2 and Ifitm-1 (Fig. 5I and J). These data
highlight the possibility that Wnt5b acts on committed progenitors in
the presence of GM-CSF. We therefore investigated cell surface marker
expression in week 1 and 2 of the CFU assay. Interestingly, Wnt5b
significantly increased the ratio of Lin+/Lin− cells after 1 week of CFU
assay (0.87 ± 0.1 for GM-CSF and 1.77 ± 0.3 for GM-CSF + Wnt5b,
p < .05, Fig. 5F), indicating higher presence of committed progenitors
Fig. 2. Effects of Wnt5a and Wnt5b on IL-3 and GM-CSF induced myeloid colony formation. A) Total numbers of colonies formed by IL-3 (10 ng/mL) in the absence
and presence of Wnt5a (50 and 200 ng/mL) and Wnt5b (50 and 200 ng/mL). Panels B-D show differential data for B) GM-CFU; C) M-CFU and D) G-CFU. E) Total
numbers of colonies formed by GM-CSF (10 ng/mL) in the absence and presence of Wnt5a and Wnt5b. Panels F–H show differential data for F) GM-CFU; G) M-CFU
and H) G-CFU. Data are presented as mean ± SEM. *p < .05, n = 6–8.
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(this data is highlighted in Supplementary Fig. 3B, where it is also easy
to compare with the lack of Wnt5b influence in presence of IL-3).
Wnt5b decreased gene expression of Dkk1 and tended to reduce Axin2
expression in the second week of CFU (0.01 ± 0.0 for GM-CSF and
0.00 ± 0.0 for GM-CSF + Wnt5b, p < .05, Figs. 5K and L). Genes
involved in non-canonical Wnt signaling (c-Fos, c-Jun and Cdc42) were
also analyzed by RT-PCR and, opposite to what was observed for IL-3,
in the presence of GM-CSF, Wnt5b upregulated these noncanonical
pathway genes.
Interestingly, at the same time we observe an increase in Lin+ po-
pulation with Wnt5b treatment in presence of GM-CSF, we also observe
early apoptosis in the Lin−. Both events might be involved in the
functional effects observed.
4. Discussion
In the hematopoietic system, Wnt ligands appear to have roles in
lineage specification, differentiation control and cell potential
[8,34,42,48,58]. Mounting evidence suggests that increased Wnt5
ligand subfamily expression in the ageing bone marrow micro-
environment may drive age-related increases in myeloid differentiation
[19]. To understand the imbalances in the ageing environment, first we
needed to investigate the roles of Wnt5 ligands in normal physiology in
more detail. We thus investigated the roles of Wnt5a and Wnt5b in IL-3-
and GM-CSF-induced HSPC myeloid differentiation using a methylcel-
lulose CFU assay. We report that Wnt5a had surprisingly little effect on
myeloid differentiation in combination with either IL-3 or GM-CSF. In
contrast, Wnt5b had striking, yet divergent effects on myeloid differ-
entiation in combination with IL-3 and GM-CSF. Divergent effects be-
tween Wnt5a and Wnt5b have been described in other tissues as well
[72]. However, since Wnt5b has not been studied as well as Wnt5a,
very little is known on its role in the hematopoietic system. While IL-3-
mediated myeloid differentiation was largely repressed by Wnt5b, GM-
CSF-induced myeloid differentiation was augmented by Wnt5b. Fur-
thermore, in the presence of IL-3, Wnt5b enhanced primitive cell self-
renewal, whereas in the presence of GM-CSF, Wnt5b accelerated dif-
ferentiation leading to progenitor cell exhaustion. Our results highlight
discrepancies between IL-3 and GM-CSF, and reveal novel effects of
Fig. 3. Similar effects of IL-3 and GM-CSF on myeloid differentiation. A) CFU assay after treatment with IL-3 (10 ng/mL) and GM-CSF (10 ng/mL). Colors represent
different types of myeloid colonies – GM-CFU = Granulocyte-monocyte colony formation unit (white); M-CFU = Monocyte colony formation unit (grey); G-
CFU = Granulocyte colony formation unit (black). B) Log10 transformed colony-areas in μm2. C) CFU replating assay after treatment with IL-3. Colors represent the
same types of colonies as described for panel A. Half-life represents calculation of the number of rounds needed to reach a 50% decay in colony formation. D) CFU
replating assay after treatment with GM-CSF. Colors represent the same types of colonies as described for panel A. Half-life represents calculation of the number of
rounds needed to reach a 50% decay in colony formation. E) Cells/colony after IL-3 and GM-CSF treatment. F) Cell number after 1 week of LC with IL-3 and GM-CSF
treatment. G) Percentage of Lin+ cells after 1 week of liquid culture (LC) with IL-3 and GM-CSF treatment. H) Percentage of Lin+ cells after 1 week of liquid culture
(LC) with IL-3 and GM-CSF treatment. I) Percentage of Lin−c-Kit+ cells after 1 week of liquid culture (LC) with IL-3 and GM-CSF treatment. J-K) Analysis of
phosphorylation of GSK3β after 15, 20 and 30 min of stimulation with IL-3 or GM-CSF (respectively) in HSPC (Lin−Sca-1+c-Kit+ − black bars) and more committed
progenitors (Lin−Sca-1−c-Kit+ − stripped bars). Comparison was done between HPSC and progenitors in each treatment. Data are presented as mean ± SEM,
except for area data, which is plotted as individual colonies and their median. *p < .05.
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Wnt5b on the hematopoietic system.
The divergent outcomes for Wnt5a and Wnt5b treatment we ob-
served are of interest, as these ligands are highly structurally related
and share significant amino acid similarity (83%) [31]. Published data
on the role of Wnt5 ligand subfamily signaling in hematopoietic dif-
ferentiation to date relates to the role of Wnt5a, whereas there are no
reports about Wnt5b regulation of cytokine-driven granulocyte and
monocyte differentiation thus far. The limited knowledge available on
the role of Wnt5b in hematopoiesis is restricted to lymphocyte and
megakaryocyte differentiation [5,39,41]. Wnt5b does appear to pro-
mote thrombopoiesis via G-protein and Ca2+ signaling in a zebrafish
model [39]. Notably, we observed that Wnt5b had divergent effects
depending on the cytokine used to support myeloid maintenance and
development.
The maintenance of progenitor cell phenotype by Wnt5b treatment
in presence of IL-3 might explain why Wnt5b caused an initial decrease
in the number of colonies in the CFU assay, followed by an increase in
the 2nd round, as primitive cells cycle less [1,7,11], forming fewer
colonies than differentiating cells in the CFU assay [46]. Our data
suggest inhibition of IL-3-induced differentiation by Wnt5b. In support
of this idea, expression of the cell cycle markers Cdk1 and Cyclin D1,
and of the primitive cell markers GATA-2 and Ifitm-1, were increased
by Wnt5b in the presence of IL-3. Thus, on a background of IL-3 acti-
vation, Wnt5b may stimulate multipotent progenitor cell self-renewal.
There is no description of Wnt5b effects on cytokine-driven myelopoi-
esis whatsoever in literature, so it is the first time it is described op-
posite results between IL-3 and GM-CSF in presence of Wnt ligands.
In contrast, we observed that in the presence of GM-CSF, Wnt5b
caused an increase in colony formation in the first round of the CFU
assay, whereas this capability decreased in later rounds. Therefore, on a
background of GM-CSF activation, which promotes proliferation [49],
Wnt5b induced differentiation of committed progenitors and con-
sequent loss of progenitor cell potential. Furthermore, some of the ef-
fects of Wnt5b were observed at the lower concentration in combina-
tion with GM-CSF already, whereas in combination with IL-3 only the
highest concentration had effects. A possible explanation for this dis-
crepancy is that Wnt5b can target multiple receptors, with a specific
receptor population being activated at the 50 ng/mL concentration that
regulates GM-CSF responses but not IL-3 responses.
The observed differences are quite striking, as IL-3 and GM-CSF
have broadly similar effects on myeloid differentiation [2,9,44,47]. The
receptors for IL-3, GM-CSF and IL-5 share a common β-chain [22]
which via interaction with their ligands can stimulate intracellular
signaling pathways such as JAK/STAT, Ras/ERK, PI3K/PKB, PLCγ2 and
PKCβ/RACK1 [22,35]. Wnt signaling has been linked to the activation
of Ras/ERK, PI3K/PKB, PLCγ2 and PKCβ/RACK1 [10,13,28,33,59,69]
and these all represent potential points of convergence in the signaling
interactions between Wnt5b and IL-3/GM-CSF.
Another explanation for the divergent effects of Wnt5b after IL-3 or
GM-CSF stimulation could be related to differences in expression of the
IL-3 and GM-CSF receptor α-chains between different cell populations
present in the assay [68]. Although IL-3 and GM-CSF produced similar
numbers of colonies of comparable sizes, IL-3 treatment generated more
primitive (Lin−Sca1+) cells than GM-CSF. Notably, the IL-3 receptor α-
chain was described to be enriched in myeloid progenitor cells relative
to more differentiated hematopoietic cell types [43]. In contrast, the
GM-CSF receptor α-chain was largely not expressed by primitive,
colony-forming bone marrow cells, whereas higher expression was
observed in more differentiated monocyte precursors, granulocytes and
monocytes. Thus, due to differential cognate receptor expression, IL-3
Fig. 4. Wnt5b maintains primitive progenitors in combination with IL-3. A) CFU Replating assay in the presence of IL-3 (10 ng/mL). B) CFU Replating assay in the
presence of Wnt5b (200 ng/mL) and IL-3. Bars show total colony number; pie charts represent types of colonies in each round of CFU reading, being white = GM-
CFU; grey =M-CFU and black = G-CFU. C) Colony-areas. D) Cell number/colony after IL-3 and IL-3 +Wnt5b. E) CFU replating of subtypes of colonies after IL-3 and
IL-3 + Wnt5b. Colors represent GM-CFU = white, M-CFU = grey; G-CFU = black. F–I) Cdk1 (F,H) and Cyclin D1 (G,I) gene expression in relation to housekeeping
genes after 1 week (F,G) and 2 weeks (H,I) of CFU assay. J-M) GATA-2 (J,L) and Ifitm-1 (K,M) gene expression in relation to housekeeping genes after 1 week (J,K)
and 2 weeks (L,M) of CFU assay. N–P) Axin2 (N), Dkk1 (O) and LRP5 (P) gene expression in relation to housekeeping genes after 2 weeks of CFU assay. P) LRP5 gene
expression in relation to housekeeping genes after 2 weeks of CFU assay. Q-S) Gene expression of proteins involved in non-canonical Wnt signaling (c-Fos, c-Jun and
Cdc42) in relation to housekeeping genes after 2 weeks of CFU assay. For gene expression, housekeeping genes used were GAPDH and β-actin. Data are presented as
mean ± SEM. *p < .05.
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could enrich for progenitor cells, whereas GM-CSF could enrich for
differentiated myeloid cell types; these populations could in turn ex-
hibit divergent responses to Wnt5b. The viability data support this and
indicate that Lin− cells are better maintained than the Lin+ cells by
Wnt5b in combination with IL-3, whereas for GM-CSF this exactly the
other way around. Another possibility is that Wnt5b is inducing cyto-
kine expression by the hematopoietic cells, as already described in lung
fibroblasts [67], with divergent downstream effects on IL-3 and GM-
CSF signaling. The latter is more likely, as we analyzed whether Wnt5b
could interfere in the expression of IL-3 and GM-CSF receptors and no
changes were observed, either in alpha or beta chains.
The finding that IL-3 increased the number of primitive cells com-
pared to GM-CSF may be related to stimulation of Wnt/β-catenin sig-
naling, as IL-3 triggered phosphorylation of GSK3β, and IL-3-treated
colonies had higher baseline gene expression of Axin2, a canonical
Wnt/β-catenin target gene, compared to GM-CSF-treated colonies.
Notably, Wnt5b augmented Axin2 gene expression in the presence of IL-
3, yet decreased Axin2 expression in the presence of GM-CSF. Thus,
primitive hematopoietic cells may be primed to activate Wnt/β-catenin
signaling in response to Wn5b. In support of this, Wnt5 signaling ac-
tivated Wnt/β-catenin signaling in short-term HSCs, yet repressed Wnt/
β-catenin signaling in more differentiated progenitors [65,67]. Ac-
cordingly, we also found that a Wnt/β-catenin pathway agonist
(CHIR99021) had opposite effects to Wnt5b when combined with GM-
CSF (Supplementary Fig. 4). However, in spite of these data, we found
no obvious GFP signal in bone marrow-derived cells of TCF/Lef:H2B-
GFP fusion Wnt reporter mice [18] and could not detect overt locali-
zation of β-catenin protein using immunofluorescence microscopy,
either at baseline or in response to cytokine stimulation. These results
are reinforced by western-blotting results, which show no difference
between cells treated with IL-3, IL-3 + Wnt5b, GM-CSF or GM-
CSF + Wnt5b, for β-catenin expression (data not shown). Thus,
whereas regulation of Wnt/β-catenin signaling by Wnt5b represents
one possible explanation, it is likely that alternative signaling pathways
participate in its effects. Such mechanisms may include typical non-
canonical Wnt pathway activation signals such as Rho/Cdc42/Rac
pathways. These pathways were previously reported to contribute to
cell signaling in ageing hematopoietic stem cells in response to Wnt5a
[19] and clearly this needs to be investigated further in future studies.
Our findings show no major effects of Wnt5a on IL-3 and GM-CSF-
driven myelopoiesis, in contrast to the significant and divergent effects
of Wnt5b. Despite 83% sequence homology [31], Wnt5a and Wnt5b
have non-overlapping effects in other cell systems including lung fi-
broblasts [61,67] and alveolar epithelial progenitor cells of the lung
(Wu, X. et al., unpublished observations). Unfortunately, limited
knowledge on FZD receptor subtype selectivity of Wnt5b is available.
Nonetheless, divergent FZD receptor subtype binding and activation by
these two ligands is the most likely explanation for the observed
functional differences between Wnt5a and Wnt5b.
It is too early to propose therapeutic uses of Wnt5a or Wnt5b an-
tagonists against ageing-associated myeloid imbalances, even more
considering the link between distorted Wnt signaling and leukemia
development [23,27,40,62,70]. However, the accumulating evidence
that switching from canonical to non-canonical Wnt signaling regulates
key cellular features of hematopoietic ageing and chronic disease
[19,67], warrants further investigation into the therapeutic
Fig. 5. Wnt5b induces committed progenitor activation and progenitor exhaustion in the presence of GM-CSF. A) CFU Replating assay in the presence of GM-CSF
(10 ng/mL). B) CFU Replating assay in the presence of Wnt5b (200 ng/mL) and GM-CSF. Pie charts represent types of colonies in each rounds of CFU reading, being
white = GM-CFU; grey = M-CFU and black = G-CFU. C) Colony-areas. D) Cell number/colony after GM-CSF and GM-CSF + Wnt5b treatment. E) CFU replating of
subtypes of colonies after GM-CSF and GM-CSF + Wnt5b treatment. F) Ratio between Lin + and Lin- populations after 1 and 2 weeks of CFU assay. G-L) Cdk1 (G),
Cyclin D1 (H), GATA-2 (I), Ifitm-1 (J), Axin2 (K), Dkk1 (L), LRP5 (M), c-Fos (N), c-Jun (O) and Cdc42 (P) gene expression in relation to housekeeping genes after
2 weeks of CFU assay. For gene expression, housekeeping genes used were GAPDH and β-actin. Data are presented as mean ± SEM. *p < .05.
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opportunities associated with inhibition of non-canonical Wnt sig-
naling. In this context, our results highlight important discrepancies
between Wnt5a and Wnt5b, and show novel effects of Wnt5b on the
hematopoietic system.
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